Ozempic Cost 2026: Prices, Insurance & Alternatives

If you’re researching Ozempic® for weight loss or type 2 diabetes management, the first surprise is the price. Without insurance, a monthly supply can cost nearly $1,000 — and many insurance plans won’t even cover it for weight loss. This guide breaks down Ozempic’s real cost in 2026, why it varies so much, what options exist, and how it compares to legal compounded versions.

Ozempic’s list price in 2026

The manufacturer’s suggested retail price from Novo Nordisk for Ozempic® without insurance is approximately $935 per month at most U.S. pharmacies. That covers one prefilled pen that lasts four weeks at standard doses.

Price varies by:

Pharmacy chain: CVS, Walgreens, Walmart, and independent pharmacies carry different markups.
Geography: prices tend to be higher in metro areas and in states with less pharmacy competition.
Manufacturer coupons: Novo Nordisk offers a savings card that can cut costs to $150/month, but with strict requirements (active commercial insurance, not Medicare or Medicaid).

Ozempic with insurance

Here’s where it gets complicated. Ozempic is FDA-approved only for type 2 diabetes. Most insurance plans cover it for that indication but not for weight loss (which would be an off-label prescription).

Typical scenarios:

You have type 2 diabetes and your plan covers it: copays typically $25–$100/month.
No diabetes, just obesity: most plans deny it. Some approve with prior authorization and documented comorbidities.
Medicare: currently does not cover Ozempic for weight loss under Part D.
Medicaid: coverage varies dramatically by state.

Calling your insurer with the correct diagnosis code and asking specifically “Is Ozempic on formulary? What tier? Are there restrictions?” is essential before committing to treatment.

Ozempic vs. Wegovy vs. Zepbound

The three are related but not identical molecules:

Ozempic® (semaglutide, Novo Nordisk): approved for type 2 diabetes. Max dose 2 mg/week.
Wegovy® (semaglutide, Novo Nordisk): approved for weight loss. Max dose 2.4 mg/week. Same molecule as Ozempic, different dose and label. Retail price: ~$1,349/month.
Zepbound® (tirzepatide, Eli Lilly): approved for weight loss. Different molecule — dual GLP-1 + GIP agonist. Price: ~$1,059/month.

If a physician “prescribes Ozempic for weight loss” when you don’t have diabetes, they’re technically prescribing off-label. Wegovy is the on-label option for weight loss — but many insurers cover one and not the other.

Compounded semaglutide: the legal alternative

Here’s where options expand. Compounded semaglutide is prepared by FDA-authorized compounding pharmacies under an individual physician prescription. It contains the same active molecule (semaglutide sodium) as Ozempic and Wegovy but at a significantly lower price.

Typical prices:

Compounded semaglutide retail: $200–$450/month depending on pharmacy and dose.
REMEVi compounded semaglutide: $249/month all-inclusive — medication, initial consult with a bilingual physician, monthly follow-up, discreet shipping.

But is it legal? Is it safe?

Yes, with important caveats:

Pharmaceutical compounding is a legal practice regulated by the FDA and state pharmacy boards.
Legitimate pharmacies are FDA-registered and use semaglutide sodium (the approved API form), not unapproved salts.
The FDA has issued warnings against products sold as “semaglutide” that contain unapproved salts or contain no semaglutide at all. Always verify that your pharmacy uses the sodium form.
Legal availability of compounding depends on the FDA shortage list; if semaglutide comes off that list, compounding may be restricted.

Total annual cost comparison

Option	Monthly price	Annual cost
Wegovy® (uninsured)	$1,349	$16,188
Ozempic® (uninsured)	$935	$11,220
Ozempic® with insurance (typical copay)	$50	$600
Compounded semaglutide retail	$350	$4,200
REMEVi compounded semaglutide	$249	$2,988

The difference between a year of retail Wegovy and a year of REMEVi is ~$13,200. That’s real — and for many patients, decisive.

What to ask your physician

Before committing to any option, these questions help:

Am I a medical candidate for GLP-1? (BMI, comorbidities, contraindications)
What’s the clinical difference between brand and compounded for my case?
Does my insurance cover any version? With what restrictions?
Does the physician understand the risks and protocols for each version?
What does month-to-month follow-up look like — does it include dose adjustments?
What happens if I don’t tolerate the medication or don’t lose weight?

A good consult should take at least 15 minutes and answer all these questions without rushing.

At REMEVi

We offer compounded semaglutide and tirzepatide with licensed bilingual physicians in your state, FDA-registered compounding pharmacies, and 100% transparent pricing — no insurance, no fine print, no hidden fees. Every prescription is reviewed by a real physician, not an algorithm.

If you want to see if you qualify, take the 5-minute quiz. A physician reviews your history within 24 hours.

See full pricing · Read the complete semaglutide guide

This information is educational. Decisions about prescription medications should be made with a licensed physician who knows your complete medical history. Last medical review: April 19, 2026.